2.395
4.15%
-0.135
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$2.53
Aprire:
$2.52
Volume 24 ore:
247.87K
Relative Volume:
0.18
Capitalizzazione di mercato:
$564.87M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-1.2672
EPS:
-1.89
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
-6.37%
1M Prestazione:
-38.30%
6M Prestazione:
-70.78%
1 anno Prestazione:
-39.53%
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
SANA | 2.39 | 564.87M | 0 | -283.26M | -273.61M | -1.89 |
VRTX | 447.21 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 737.75 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 586.52 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.92 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 102.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
2023-09-05 | Iniziato | Citigroup | Buy |
2023-08-14 | Iniziato | TD Cowen | Market Perform |
2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
2021-03-01 | Iniziato | BofA Securities | Buy |
2021-03-01 | Iniziato | Goldman | Neutral |
2021-03-01 | Iniziato | JP Morgan | Neutral |
2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Sana Biotechnology: The Story Becomes Murkier (NASDAQ:SANA) - Seeking Alpha
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
Sana Biotechnology (NASDAQ:SANA) Reaches New 1-Year LowHere's Why - MarketBeat
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
10 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money
Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot - Investing.com India
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - Quantisnow
Sana Biotechnology, Inc. (NASDAQ:SANA) Holdings Lowered by Baillie Gifford & Co. - MarketBeat
Sana Biotechnology stock hits 52-week low at $2.75 By Investing.com - Investing.com Australia
FMR LLC's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotechnology stock hits 52-week low at $2.75 - Investing.com India
Sana Biotech sustains stock target with Buy rating on Q3 earnings - Investing.com Nigeria
Analyst keeps Buy on Sana Biotechnology, adjusts outlook as blood cancer competition rises - Investing.com Canada
Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot By Investing.com - Investing.com Canada
Sana Biotechnology (NASDAQ:SANA) Hits New 1-Year LowWhat's Next? - MarketBeat
Sana Biotechnology Inc Still Hasn’t Convinced Analysts? - Stocks Register
HC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA) - MarketBeat
Sana Biotechnology downgraded to Market Perform from Outperform at JMP Securities - MSN
Sana Biotechnology, Inc. Reports Q3 2024 Financial Results - TipRanks
Sana: Q3 Earnings Snapshot - The Washington Post
Sana Biotechnology Inc. (SANA) Quarterly 10-Q Report - Quartzy
Earnings Flash (SANA) SANA BIOTECHNOLOGY Reports Q3 Loss $-0.27 Per Share - Marketscreener.com
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - The Manila Times
HC Wainwright Issues Positive Estimate for SANA Earnings - Defense World
HC Wainwright Issues Optimistic Forecast for SANA Earnings - MarketBeat
Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com Australia
Sana lowered to market perform by JMP over data uncertainty - MSN
Sana Biotechnology (NASDAQ:SANA) Hits New 52-Week Low on Analyst Downgrade - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat
Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com
Sana to lay off staff, deepen autoimmune focus in latest retrenchment - BioPharma Dive
500: Something went wrong - Investing.com UK
Sana Biotechnology stock hits 52-week low at $3.05 By Investing.com - Investing.com Canada
JMP Securities Downgrades Sana Biotechnology (NASDAQ:SANA) to Market Perform - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com
Sana Biotechnology Announces Increased Focus on Type 1 - GlobeNewswire
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Up 7.7%Still a Buy? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4%What's Next? - MarketBeat
Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey
Biotech stock tumbles after unexplained 1,446% gain - MSN
Sana Biotechnology Inc (SANA) looking to reclaim success with recent performance - SETE News
Sana Biotechnology Inc [SANA] Stock sold by Insider Mulligan Richard for $0.61 million - Knox Daily
Market Insights: Sana Biotechnology Inc (SANA)’s Notable Gain of 4.18, Closing at 3.99 - The Dwinnex
Sana Biotechnology Inc (SANA)’s stock price in review: A technical analysis - US Post News
Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sana Biotechnology Inc Azioni (SANA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Mulligan Richard | Director |
Sep 24 '24 |
Sale |
4.08 |
150,000 |
612,570 |
2,848,121 |
Mulligan Richard | Director |
Sep 25 '24 |
Sale |
3.89 |
150,000 |
583,170 |
2,698,121 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):